Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: In vitro study of isolated working rat heart model

Pathophysiology

Volumn 9, Issue 1, 2002, Pages 27-32

  Dobšák, Petr ^a   Siegelova, J ^a   Wolf, J E ^b   Rochette, L ^b   Eicher, J C ^b   Vasku, J ^c   Kuchtickova, S ^d   Horky, M ^d  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Vacord Bioengineering Res Company   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Cardioplegia; Deferoxamine; Free radicals; Heart graft; Isolated rat heart

Indexed keywords

DEFEROXAMINE; MALONALDEHYDE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART FIBRILLATION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART RATE; IN VITRO STUDY; INCIDENCE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036773760     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(02)00054-8     Document Type: Article

References (35)

1. Stringham J.C., Southard J.H., Hegge J., Triemstra L., Fields B.L., Belzer F.O. Limitations of heart preservation by cold storage. Transplantation. 53:1992;287-294.
2. Hearse D.J., Bolli R. Reperfusion induced injury: manifestations, mechanisms and clinical relevance. Cardiovasc. Res. 26:1992;101-108.
3. Lojek A., Cerny J., Nemec P., Nicovsky J., Soska V., Ciz M., Slavikova M., Kubala L.2. Phagocyte-induced oxidative stress in patients with hemodialysis treatment and organ transplantation. Bio. Factors. 8:1998;165-168.
4. Wikman-Coffelt J., Wagner S., Wu S., Parmley W. Alcohol and pyruvate cardioplegia: twenty-four-hours in situ preservation of hamster hearts. J. Thorac. Cardiovasc. Surg. 101:1991;509-516.
5. Kojima S., Wu S.T., Wikmann-Coffelt J. Eighteen-hours preservation of rat hearts with hexanol and pyruvate cardioplegia. J. Am. Colloid Cardiol. 21:1993;1238-1244.
6. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 47:(3):2000;446-456.
7. Kirschner R.E., Fantini G.A. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J. Am. Colloid Surg. 179:1994;103-117.
8. Eicher J.C., Gabrielle F., Abadie C., Maupoil V., Wolf J.E., David M., Rochette L. Experimental preservation of the heart transplant: effects of deferoxamine on functional recovery and lipid peroxidation of the isolated-perfused rat heart subjected to ischemia and reperfusion. Transplant Proc. 27:1995;654.
9. Kannan K., Jain S.K. Oxidative stress and apoptosis. Pathophysiology. 7:2000;153-163.
10. Drossos G., Lazou A., Panagopoulos P., Westaby S. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann. Thorac. Surg. 59:1995;162-172.
11. Nicholson S.C., Squier M., Ferguson M., Nagy Z., Westaby S., Evans R.D. Effect of desferrioxamine cardioplegia on ischemia-reperfusion injury in isolated rat heart. Ann. Thorac. Surg. 63:1997;1003-1011.
12. Yagi K.A. A simple assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
13. Maupoil V., Rochette L. Evaluation of free radical formation during global cold ischemia and reperfusion in isolated perfused rat heart. Cardiovasc. Drugs Ther. 2:1988;615-621.
14. Zweier J.L., Kuppusamy P., Williams R., Rayburn B.K., Smith D., Weisfeldt M.L., Flaherty J.T. Measurement and characteristics of postischemic free radical generation in the isolated perfused heart. J. Biol. Chem. 264:1989;18890-18895.
15. Spencer K.T., Lindower P.D., Buettner G.R., Kerber R.E. Transition metals chelators reduce directly measured myocardial free radical production during reperfusion. J. Cardiovasc. Pharmacol. 32:(3):1998;343-348.
16. Karck M., Tanaka S., Berenshtein E., Sturm, Haverich A., Chevion M. The push-and-pull mechanism to scavenge redox-active transition metals: a novel concept in myocardial protection. J. Thorac. Cardiovasc. Surg. 121:(6):2001;1169-1178.
17. Jacob A.K., Hotchkiss R.S., DeMeester S.L., Hiramatsu M., Karl I.E., Swanson P.E., Cobb J.P., Buchman T.G. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery. 122:1997;243-253.
18. Desole M.S., Sciola L., Sircana S., Godani C., Migheli R., Delogu M.R., Piras G., De Natale G., Miele E. Protective effect of deferoxamine on sodium nitroprusside-induced apoptosis in PC12 cells. Neurosci. Lett. 247:1998;1-4.
19. Terwel D., Nieland L.J., Schutte B., Reutelingsperger C.P., Ramaekers F.C., Steinbusch H.W. S-nitroso-N-penicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules. Eur. J. Pharmacol. 400:(1):2000;19-33.
20. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K.I., Miller M.P., Marquis J.C., Baraban J.M., Semenza G.L., Ratan R.R. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cipl), and erythropoietin. J. Neurosci. 19:1999;9821-9830.
21. Kyriakou D., Eliopoulos A.G., Papadakis A., Alexandrakis M., Eliopoulos G.D. Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassemia patients receiving desferrioxamine. Eur. J. Haematol. 60:1998;21-27.
22. Hsieh C., Yen M., Lau Y. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc. Res. 49:2001;135-145.
23. Lee T., Chau L. Fas/Fas ligand /mediated death pathway is involved in oxLDL/induced apoptosis in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 280:(3):2001;709-718.
24. Hileti D., Panayiotidis P., Hoffbrand A.V. Iron chelators induce apoptosis in proliferating cells. Br. J. Haematol. 89:1995;181-187.
25. Leardi A., Caraglia M., Selleri C., Pepe S., Pizzi C., Notaro R., Fabbrocini A., De Lorenzo S., Musico M., Abbruzzese A., Bianco A.R., Tagliaferri P. Desferioxamine increases iron depletion and apoptosis induced by ara-c of human myeloid leukaemic cells. Br. J. Haematol. 102:1998;746-752.
26. Salahudeen A.K., Joshi And M., Jenkins J.K. Apoptosis versus necrosis during cold storage and rewarming of human renal proximal tubular cells. Transplantation. 72:(5):2001;798-804.
27. Buttke (tm) P.A. Sandstrom, Oxidative stress as a mediator of apoptosis. Immunol. Today 15 (1994) 7-10.
28. Li P.F., Dietz R.a, von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle. FEBS Lett. 404:1997;249-252.
29. Wallace D.C. Mitochondrial diseases in man and mouse. Science. 283:1999;1482-1488.
30. Crawford D.R., Abramova N.E., Davies K.J. Oxidative stress causes a general, calcium-dependent degradation of mitochondrial polynucleotides. Free Radic. Biol. Med. 25:1998;1106-1111.
31. Ding W.X., Shen H.M., Ong C.N. Critical role of reactive oxygen species and mitochondrial permeability transition in microcystin-induced rapid apoptosis in rat hepatocytes. Hepatology. 32:(3):2000;547-555.
32. Richter C. Reactive oxygen and DNA damage in mitochondria. Mutat. Res. 275:1992;249-255.
33. Carden D.L., Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190:2000;255-266.
34. Yue T.L., Ma X.L., Wang X., Romanic A.M., Liu G.L., Louden C., Gu J.L., Kumar S., Poste G., Ruffolo R.R. Jr, Feuerstein G.Z. Possible involvement of stress-activated protein kinase pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ. Res. 82:1998;166-174.
35. Dobsak P., Courderot-Masuyer C., Zeller M., Vergely C., Laubriet A., Assem M., Eicher J.C., Teyssier J.R., Wolf J.E., Rochette L. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J. Cardiovasc. Pharmacol. 34:1999;651-659.